BioCurity Pharmaceuticals Inc. (Equity)
Funding Details
Awarder
StartEngine
Date Award
January 1, 2024
Vertical
Biopharmaceuticals
Funding URL
View Funding Page
Valuation
$36,320,000
Funding Amount
$228,429,000,000
Company Info
Traction
BioCurity has developed drugs to protect cancer patients from the side effects of radiation therapy. They have issued US patents and have a growing IP portfolio. The management team is focused on meeting development milestones to increase the company's valuation.
Organizations Involved
MD Anderson Cancer Center, State University
Founders
Dr. Cheryl Baker, Sam Merchant, Nancy Cass
Market
Healthcare
Location
Jupiter, FL, US
Coinvestors
StartEngine Crowdfunding Inc.
Company Description

BioCurity is a biopharmaceutical company developing drugs to transform radiation therapy. Their mission is to prevent certain side effects of radiation therapy for cancer patients. The proposed drugs under development are from BioCurity’s patented technology and have been preclinically tested for multiple cancers including breast, lung, head and neck, prostate, and colorectal cancer.

Links
Website
Back to HomeBack to Biopharmaceuticals DealsView Funding Announcement